癌症治疗的WD重复域5抑制剂:不是你想的
April M Weissmiller1, Stephen W Fesik2,3,4, William P Tansey2,5
1Department of Biology, Middle Tennessee State University, Murfreesboro, TN 32132, USA.
Journal of clinical medicine
|January 11, 2024
概括
WDR5抑制剂不是表观遗传调节剂,而是针对抗癌治疗的核糖体. 了解这种机制是利用它们有效地抑制瘤的关键.
科学领域:
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- WDR5是一种参与表观遗传调节和线粒分裂的核蛋白.
- WDR5是抗癌疗法的目标,具有临床前开发中的抑制剂和降解剂.
- 目前的WDR5抑制剂被认为通过向基因组甲基化来作为表观遗传调节剂发挥作用.
研究的目的:
- 挑战WDR5抑制剂作为表观遗传调节剂的普遍概念.
- 提出一个统一的WDR5抑制剂作用模型.
- 澄清WDR5抑制剂的机制,以改善抗癌疗法.
主要方法:
- 对关于WDR5功能和抑制机制的现有文献的审查.
- 对有关WDR5抑制剂活性的当代数据的分析.
- 开发一种新的WDR5抑制剂作用机制模型.
主要成果:
- 作为表观遗传调节剂的WDR5抑制剂的前提没有得到当前证据的支持.
- 一个统一的模型假设WDR5抑制剂作为核糖体导向的药物.
- 这种核糖体向机制解释了WDR5抑制剂的抗癌特性.
结论:
- WDR5抑制剂的抗癌作用源于核糖体向,而不是表观遗传调制.
- 修订对WDR5抑制剂机制的理解对于治疗开发至关重要.
- 利用WDR5抑制剂作为核糖体导向疗法为癌症治疗提供了新的途径.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.1K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
205
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
205
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
